NICHI-IKO PHARMACEUTICAL CO LIMITED — Etanercept Importer Profile
Pharmaceutical Importer · #8 buyer for Etanercept · $2.5M import value · 51 shipments · JAPAN · DGFT Verified
NICHI-IKO PHARMACEUTICAL CO LIMITED is the #8 importer of Etanercept from India with $2.5M in import value and 51 verified shipments. NICHI-IKO PHARMACEUTICAL CO LIMITED holds a 19.7% market share in Etanercept imports based in JAPAN. The company sources from 1 verified supplier across 8 formulations shipped to 1 country.
NICHI-IKO PHARMACEUTICAL CO LIMITED — Etanercept Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Etanercept to NICHI-IKO PHARMACEUTICAL CO LIMITED?
Verified from 51 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| LUPIN LIMITED | $2.5M | 51 | 100.0% |
NICHI-IKO PHARMACEUTICAL CO LIMITED sources Etanercept from 1 verified Indian supplier based on 51 customs records. The primary supplier is LUPIN LIMITED accounting for 100.0% of imports.
How Does NICHI-IKO PHARMACEUTICAL CO LIMITED Compare to Nearest Etanercept Importers?
Buyers ranked immediately above and below #8 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | PRESPACK SP Z.O.O | POLAND | $600.0K | 12 | $50.0K |
| 5 | NICHI-IKO PHARMACEUTICAL CO., LTD | JAPAN | $550.0K | 11 | $50.0K |
| 8 | NICHI-IKO PHARMACEUTICAL CO LIMITED ★ | JAPAN | $550.0K | 11 | $50.0K |
| 10 | PRESPACK SP Z,O,O | POLAND | $300.0K | 6 | $50.0K |
| 6 | PSK PHARMA | RUSSIA | $200.0K | 4 | $50.0K |
NICHI-IKO PHARMACEUTICAL CO LIMITED ranks #8 among 64 Etanercept importers from India. Average shipment value of $50.0K compared to the market average of $95.3K. The closest competitors by value are PRESPACK SP Z.O.O and NICHI-IKO PHARMACEUTICAL CO., LTD.
Where Does NICHI-IKO PHARMACEUTICAL CO LIMITED Import Etanercept To?
Destination countries from 51 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| JAPAN | $2.5M | 51 | 100.0% |
NICHI-IKO PHARMACEUTICAL CO LIMITED imports Etanercept to 1 country. The primary destination is JAPAN receiving 100.0% of shipments worth $2.5M.
What Etanercept Formulations Does NICHI-IKO PHARMACEUTICAL CO LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| ETANERCEPT BS 50MG PEN 1ML SC NICHIIKO | $850.0K | 17 |
| ETANERCEPT BS 50MG PEN 1 ML SC NICHIIKO | $450.0K | 9 |
| ETANERCEPT BS 25MG SYR 0.5ML SC NICHIIKO | $400.0K | 8 |
| ETANERCEPT BS 25MG SYR 0.5 ML SC NICHIIK | $300.0K | 6 |
| ETANERCEPT BS 50MG SYR 1 ML SC NICHIKO | $250.0K | 5 |
| ETANERCEPT BS 50MG SYR 1ML SC NICHIIKO | $200.0K | 4 |
| ETANERCEPT BS 50MG PEN 1ML SC NICHIIKONOS | $50.0K | 1 |
| ETANERCEPT ISRS STANDARDS VIALS *LUT ARN | $37 | 1 |
NICHI-IKO PHARMACEUTICAL CO LIMITED imports 8 distinct Etanercept formulations from India. The top formulation is ETANERCEPT BS 50MG PEN 1ML SC NICHIIKO with 17 shipments worth $850.0K.
Regulatory Requirements: Importing Etanercept into Japan
What NICHI-IKO PHARMACEUTICAL CO LIMITED and other importers must comply with to import Etanercept from India
Regulatory Authority
Pharmaceuticals and Medical Devices Agency (PMDA)
Approval Process for Generic Etanercept
Generic Drug Application under Japan Pharmaceutical Affairs Act. Requires dissolution and bioequivalence studies per PMDA guidelines. Japanese data bridging often required.
Typical timeline: 12–24 months
GMP Requirements
Japanese GMP (J-GMP) compliance; PMDA on-site inspection of manufacturing facility
Import Licence & Documentation
Marketing Authorization Holder (MAH) must be a Japanese entity; Foreign Manufacturer Registration (Accreditation) required
Labeling & Packaging
Japanese language labeling mandatory; Japanese Pharmacopoeia compliance
Note: Japan requires Yen-denominated pricing approval (NHI drug price listing). Stability data under ICH Zone IVb conditions.
Regulatory information is provided for general reference based on publicly available PMDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with PMDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Etanercept from India and How Much Does NICHI-IKO PHARMACEUTICAL CO LIMITED Import?
India exported $6.1M worth of Etanercept through 251 shipments from 27 suppliers to 29 countries, serving 64 buyers globally. NICHI-IKO PHARMACEUTICAL CO LIMITED imports $2.5M of this total, accounting for 19.7% of India's Etanercept exports with 51 shipments from JAPAN. This is verified from 51 customs shipment records covering 8 distinct formulations.
What Is the Average Order Value for NICHI-IKO PHARMACEUTICAL CO LIMITED's Etanercept Imports?
NICHI-IKO PHARMACEUTICAL CO LIMITED's average Etanercept order value is $49.0K per consignment, based on 51 shipments totaling $2.5M. NICHI-IKO PHARMACEUTICAL CO LIMITED is based in JAPAN and ranks #8 among all Etanercept importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Etanercept to NICHI-IKO PHARMACEUTICAL CO LIMITED?
NICHI-IKO PHARMACEUTICAL CO LIMITED sources Etanercept from 1 verified Indian supplier: LUPIN LIMITED ($2.5M, 100.0%). This is based on 51 customs records.
How Does NICHI-IKO PHARMACEUTICAL CO LIMITED Compare to Other Etanercept Importers?
NICHI-IKO PHARMACEUTICAL CO LIMITED ranks #8 among 64 Etanercept importers from India with a 19.7% market share. The top 3 importers are NICHI-IKO PHARMACEUTICAL CO LTD ($1.4M), PRESPACK JACEK KARONSKI ($950.0K), PRESPACK JACEK KARONSKI UL SADOWA ($700.0K). NICHI-IKO PHARMACEUTICAL CO LIMITED processed 51 shipments from JAPAN.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Etanercept — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Etanercept shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: NICHI-IKO PHARMACEUTICAL CO LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as NICHI-IKO PHARMACEUTICAL CO LIMITED's capped import value divided by total capped export value for Etanercept across all Indian exporters.
- 5.Verified Records: This page is backed by 51 individual customs records matching NICHI-IKO PHARMACEUTICAL CO LIMITED importing Etanercept, covering 8 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 29+ countries, 64+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Etanercept Import Data for NICHI-IKO PHARMACEUTICAL CO LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for NICHI-IKO PHARMACEUTICAL CO LIMITED's Etanercept imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
NICHI-IKO PHARMACEUTICAL CO LIMITED
Company Profile
Multiple products · $0 total trade · Multiple categories
NICHI-IKO PHARMACEUTICAL CO LIMITED × Etanercept
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for NICHI-IKO PHARMACEUTICAL CO LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Etanercept. For current order-level data, contact TransData Nexus.